YONDELIS (Trabectedin) Single Patient Compassionate Use / Expanded Access

Expanded access is no longer available for this treatment.
Sponsor:
Collaborator:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Information provided by (Responsible Party):
University of Texas Southwestern Medical Center
ClinicalTrials.gov Identifier:
NCT01427582
First received: August 30, 2011
Last updated: NA
Last verified: August 2011
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: Expanded access is no longer available for this treatment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given